Table 1.
Mechanism of action and GI50 values of agents used
Cmpd | Mechanism of Action | U2OS GI50 (μM) | Ref | |
---|---|---|---|---|
| ||||
Mean | SD | |||
V158411 | Chk1 Inhibitor | 0.82 | 0.1 | [11] |
VX-970 | ATR Inhibitor | 3.5 | 0.77 | [50] |
AZD1775 | Wee1 Inhibitor | 0.27 | 0.036 | [51] |
Gemcitabine | Chain terminator & RNR inhibitor | 0.012 | 0.001 | |
Camptothecin | Topo I inhibitor | 0.25 | 0.003 | |
Etoposide | Topo II inhibitor | 4.2 | 0.32 | |
LY2603618 | Chk1 inhibitor | 0.67 | 0.05 | [52] |
MK8776 | Chk1 inhibitor | 0.82 | 0.05 | [53] |
PF-477736 | Chk1 inhibitor | 0.71 | 0.06 | [54] |
Cisplatin | DNA alkylator | 7.5 | 0.77 | |
Hydroxyurea | RNR inhibitor | 2800 | 1100 | |
KU-60019 | ATM inhibitor | 24 | 9.2 | [55] |
NU7746 | DNA-PKcs inhibitor | 8.6 | 0.48 | [56] |